NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Field Medical

Field Medical

Private
CaliforniaHealthcare & Life Scienceshttps://www.fieldmedicalinc.com/

Last Round

Series B

Jul 1, 2025

Est. Valuation

$95M

Total Funding Raised

$89M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Field Medical is a clinical-stage medical device company that develops pulsed field ablation (PFA) technology for the treatment of cardiac arrhythmias, including ventricular tachycardia and atrial fibrillation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

pulsed field ablationPFAcardiac ablationelectrophysiologycardiac arrhythmiacatheter technologymedical deviceelectrophysiology labcardiac surgeryrazor-razorblade modelclinical-stage medtechtissue-specific ablation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Field Medical Comparables

Compare Field Medical with similar companies based on industry and business-model similarity.

Field Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adagio Medical
84%
Kardium
83%
Cortex, Inc.
81%

Field Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 1, 2025
Series AApr 21, 2025
SeedSep 18, 2023

Key People

Founding team and executive leadership

Mark A. Turco

Chief Executive Officer

Executive Team

Steven Mickelsen

Chief Executive Officer

Executive Team

Kit Schneider

Chief Technology Officer

Executive Team

Field Medical Investors

Notable investors and investment history

Field Medical investors
InvestorRounds
Cue Growth PartnersSeries B
BioStar CapitalSeries B
CUE Growth PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 16, 2026

    Mark A. Turco, MD, appointed as new Chief Executive Officer.

  • Feb 5, 2026

    Presented data at the AF Symposium 2026.

Field Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Field Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Field Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersCalifornia
Employee Range528
Year Founded2022
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.